Eagle Pharmaceuticals Market Cap

Eagle Pharmaceuticals has a market cap or net worth of $39.07 million as of July 3, 2025. Its market cap has decreased by -19.56% in one year.

Market Cap

39.07M

Enterprise Value

n/a

Revenue

257.55M

Ranking

n/a

PE Ratio

3.29

Stock Price

$3.00

Market Cap Chart

Since February 12, 2014, Eagle Pharmaceuticals's market cap has decreased from 39.11M to 39.07M, a decrease of -0.10%. That is a compound annual growth rate of -0.01%.

Market Cap History

Date	Market Cap	% Change
Jul 3, 2025	39.07M	500.00%
Dec 31, 2024	6.51M	-90.41%
Dec 29, 2023	67.92M	-82.15%
Dec 30, 2022	380.45M	-42.14%
Dec 31, 2021	657.57M	8.37%
Dec 31, 2020	606.81M	-26.12%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo, Inc.	1.59B
Veradigm	823.67M
Elite Pharmaceuticals	716.90M
Nika Pharmaceuticals	708.22M
Tian'an Technology Group	628.15M
Glass House Brands	540.25M
American Oncology Network	443.39M
Northwest Biotherapeutics	363.62M

Market Cap Rankings